Form 4: Elanco Animal Health Executive Ramiro Martin Cabral Reports Stock Transactions
SEC Filing
Elanco Animal Health's Executive Vice President, Ramiro Martin Cabral, reports acquisition and disposal of common stock on February 27, 2024.
Summary
- On February 27, 2024, Ramiro Martin Cabral, an Executive Vice President at Elanco Animal Health Inc., acquired 21,342 shares of common stock at $0 per share.
- On the same day, Cabral disposed of 9,539 shares of common stock at a price of $16.46 per share.
- Following these transactions, Cabral directly owns 149,650 shares of Elanco Animal Health Inc.
- The transactions were reported on February 29, 2024.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of stock acquisition and disposal. |
| 02/29/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.